External validators converging: multiple independent outside parties have recently, concretely endorsed the company with
The model's full reasoning — Q3 2018 call → NO我们根据提供的文本判断。管理层提到了Perkin Elmer的合作(具体行动),以及HemeScreen的订单(来自医生),还有IV-Cell的外部测试。但需要确认是否有至少两个独立外部方最近采取了具体行动。Perkin Elmer是明确的合作伙伴,有共同营销协议。HemeScreen有来自医生的订单,但医生是客户,算独立方。另外提到“interested parties”测试IV-Cell,但未明确具体行动。还有病理服务客户增长。但关键是管理层是否将这些汇聚视为验证轨迹且贡献还在未来。文本中Ilan说“Perkin Elmer...selected ICP...co-marketing agreement”,以及“HemeScreen...already received numerous orders”,还有“IV-Cell...interested parties...test”。但IV-Cell的测试可能只是试用,不算承诺。另外病理服务增长是已反映在结果中。需要严格判断:至少两个独立方有具体行动。Perkin Elmer是合作,HemeScreen的订单是客户购买,算具体行动。但管理层是否将两者联系起来作为验证?文本中Ilan说“Perkin Elmer...strong indicator of revenue potential”,以及“HemeScreen...response positive...orders”。但未明确说这些汇聚验证轨迹。另外,管理层提到“several potential collaborations”但未具体。所以可能只有Perkin Elmer是明确的大动作,HemeScreen的订单是客户,但客户订单是常规销售,且已反映在收入中?HemeScreen刚推出两周,订单是新的,但属于销售,可能算具体行动。但需要看是否“recently”且“costly to reverse”。订单可能可取消。另外,IV-Cell的外部测试未明确。所以可能只有Perkin Elmer一个明确的外部方。因此答案应为NO。注意问题要求“at least two genuinely separate outside parties”。这里只有Perkin Elmer明确,其他如医生订单是客户,但客户订单是常规业务,且管理层未将其作为独立验证。另外,病理服务增长是已有结果。所以NO。
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| MMLP | Martin Midstream Partners L.P. | Q2 2024 | 2024-07-18 | B |
| CRGO | Freightos Limited | Q1 2024 | 2024-05-20 | C+ |
| ERO | Ero Copper Corp. | Q1 2024 | 2024-05-10 | A |
| AZEK | The AZEK Company Inc. | Q2 2024 | 2024-05-08 | B+ |
| AES | The AES Corporation | Q1 2024 | 2024-05-03 | C+ |
| WEC | WEC Energy Group, Inc. | Q1 2024 | 2024-05-01 | A |
| DUOT | Duos Technologies Group, Inc. | Q4 2023 | 2024-04-01 | F |
| ASM | Avino Silver & Gold Mines Ltd. | Q4 2023 | 2024-03-21 | C+ |
| KOPN | Kopin Corporation | Q4 2023 | 2024-03-14 | C+ |
| GIII | G-III Apparel Group, Ltd. | Q4 2024 | 2024-03-14 | C |
| NICE | NICE Ltd. | Q4 2023 | 2024-02-22 | B+ |
| HP | Helmerich & Payne, Inc. | Q1 2024 | 2024-01-30 | C |
| EMKR | EMCORE Corporation | Q4 2023 | 2023-12-12 | C+ |
| BRBR | BellRing Brands, Inc. | Q4 2023 | 2023-11-21 | B+ |
| ICCM | IceCure Medical Ltd | Q3 2023 | 2023-11-15 | D |
| AIRG | Airgain, Inc. | Q3 2023 | 2023-11-09 | F |
| EFXT | Enerflex Ltd. | Q3 2023 | 2023-11-09 | C+ |
| NVAX | Novavax, Inc. | Q3 2023 | 2023-11-09 | F |
| SCPH | scPharmaceuticals Inc. | Q3 2023 | 2023-11-08 | B |
| QTRX | Quanterix Corporation | Q3 2023 | 2023-11-07 | B |
| AEP | American Electric Power Company, Inc. | Q3 2023 | 2023-11-02 | C+ |
| APAM | Artisan Partners Asset Management Inc. | Q3 2023 | 2023-11-01 | C+ |
| DXLG | Destination XL Group, Inc. | Q2 2023 | 2023-08-24 | D |
| KMDA | Kamada Ltd. | Q2 2023 | 2023-08-16 | B+ |
| APPS | Digital Turbine, Inc. | Q1 2024 | 2023-08-08 | D |
| SITM | SiTime Corporation | Q2 2023 | 2023-08-02 | C+ |
| MBLY | Mobileye Global Inc. | Q2 2023 | 2023-07-28 | B+ |
| IMAX | IMAX Corporation | Q2 2023 | 2023-07-26 | B+ |
| GVP | GSE Systems, Inc. | Q1 2023 | 2023-05-15 | D |
| PFIE | Profire Energy, Inc. | Q1 2023 | 2023-05-13 | B |
| SPIR | Spire Global, Inc. | Q1 2023 | 2023-05-10 | B |
| INGN | Inogen, Inc. | Q1 2023 | 2023-05-05 | F |
| BRX | Brixmor Property Group Inc. | Q1 2023 | 2023-05-02 | A |
| CRBG | Corebridge Financial, Inc. | Q4 2022 | 2023-02-22 | B |
| TOST | Toast, Inc. | Q4 2022 | 2023-02-16 | C+ |
| ADPT | Adaptive Biotechnologies Corporation | Q4 2022 | 2023-02-14 | C+ |
| PI | Impinj, Inc. | Q4 2022 | 2023-02-08 | B+ |
| ARWR | Arrowhead Pharmaceuticals, Inc. | Q4 2022 | 2022-11-28 | D |
| CUE | Cue Biopharma, Inc. | Q3 2022 | 2022-11-14 | D |
| BLZE | Backblaze, Inc. | Q3 2022 | 2022-11-11 | D |
| ICL | ICL Group Ltd | Q3 2022 | 2022-11-09 | B+ |
| SIBN | SI-BONE, Inc. | Q3 2022 | 2022-11-07 | C+ |
| MEC | Mayville Engineering Company, Inc. | Q3 2022 | 2022-11-05 | B+ |
| SYY | Sysco Corporation | Q1 2023 | 2022-11-01 | C+ |
| AWRE | Aware, Inc. | Q3 2022 | 2022-10-30 | F |
| EVGO | EVgo, Inc. | Q2 2022 | 2022-08-09 | C+ |
| DM | Desktop Metal, Inc. | Q2 2022 | 2022-08-08 | F |
| FLR | Fluor Corporation | Q2 2022 | 2022-08-05 | D |
| CRL | Charles River Laboratories International | Q2 2022 | 2022-08-03 | C |
| SYM | Symbotic Inc. | Q3 2022 | 2022-08-01 | B+ |
| OGI | OrganiGram Holdings Inc. | Q3 2022 | 2022-07-14 | B+ |
| FLYW | Flywire Corporation | Q1 2022 | 2022-05-14 | B+ |
| ZVIA | Zevia PBC | Q1 2022 | 2022-05-12 | B |
| VNRX | VolitionRx Limited | Q1 2022 | 2022-05-12 | F |
| OPK | OPKO Health, Inc. | Q1 2022 | 2022-05-09 | D |
| BXP | Boston Properties, Inc. | Q1 2022 | 2022-05-03 | A |
| SOPH | SOPHiA GENETICS SA | Q4 2021 | 2022-03-15 | C |
| CDXC | ChromaDex Corporation | Q4 2021 | 2022-03-09 | C+ |
| KD | Kyndryl Holdings, Inc. | Q4 2021 | 2022-03-01 | C+ |
| FLUX | Flux Power Holdings, Inc. | Q2 2022 | 2022-02-10 | D |
| GTES | Gates Industrial Corporation plc | Q4 2021 | 2022-02-07 | C+ |
| OOMA | Ooma, Inc. | Q3 2022 | 2021-12-02 | B+ |
| GFS | GLOBALFOUNDRIES Inc. | Q3 2021 | 2021-11-30 | A |
| BFI | BurgerFi International, Inc. | Q3 2021 | 2021-11-12 | C |
| ALHC | Alignment Healthcare, Inc. | Q3 2021 | 2021-11-06 | B+ |
| CYBR | CyberArk Software Ltd. | Q3 2021 | 2021-11-04 | B+ |
| WMB | The Williams Companies, Inc. | Q3 2021 | 2021-11-02 | B |
| ASAN | Asana, Inc. | Q2 2022 | 2021-09-01 | B+ |
| LOPE | Grand Canyon Education, Inc. | Q2 2021 | 2021-08-08 | C |
| UFI | Unifi, Inc. | Q4 2021 | 2021-08-07 | B |
| CRS | Carpenter Technology Corporation | Q4 2021 | 2021-08-01 | A |
| EHTH | eHealth, Inc. | Q2 2021 | 2021-07-29 | F |
| TENB | Tenable Holdings, Inc. | Q2 2021 | 2021-07-27 | A |
| ADSK | Autodesk, Inc. | Q3 2019 | 2018-11-20 | A |
| ALB | Albemarle Corporation | Q3 2018 | 2018-11-08 | B |
| T | AT&T Inc. | Q3 2018 | 2018-10-24 | C+ |
| PRIM | Primoris Services Corporation | Q2 2018 | 2018-08-11 | C+ |
| YUM | Yum! Brands, Inc. | Q2 2018 | 2018-08-02 | C |
| XOM | Exxon Mobil Corporation | Q2 2018 | 2018-07-27 | C |
| MKC | McCormick & Company, Incorporated | Q2 2018 | 2018-06-28 | C+ |
| HPE | Hewlett Packard Enterprise Company | Q2 2018 | 2018-05-22 | B+ |
| ILMN | Illumina, Inc. | Q1 2018 | 2018-04-24 | A |
| ACHC | Acadia Healthcare Company, Inc. | Q4 2017 | 2018-02-22 | C+ |
| EPAM | EPAM Systems, Inc. | Q4 2017 | 2018-02-16 | B |
| INST | Instructure's | Q4 2017 | 2018-02-12 | B+ |
| UNH | UnitedHealth Group Incorporated | Q4 2017 | 2018-01-16 | A |
| CPK | Chesapeake Utilities Corporation | Q3 2017 | 2017-11-10 | A |
| MITK | Mitek Systems, Inc. | Q4 2017 | 2017-11-07 | C+ |
| MKTX | MarketAxess Holdings Inc. | Q3 2017 | 2017-10-25 | C+ |
| HSTM | HealthStream, Inc. | Q3 2017 | 2017-10-24 | C |
| GNTX | Gentex Corporation | Q3 2017 | 2017-10-20 | B |
| MXL | MaxLinear, Inc. | Q2 2017 | 2017-08-08 | C+ |
| CNS | Cohen & Steers, Inc. | Q2 2017 | 2017-07-20 | B |
| PTC | PTC Inc. | Q3 2017 | 2017-07-19 | C+ |
| PLAB | Photronics, Inc. | Q2 2017 | 2017-05-17 | C+ |
| IONS | Ionis Pharmaceuticals, Inc. | Q1 2017 | 2017-05-09 | C |
| BP | BP p.l.c. | Q4 2016 | 2017-02-07 | B+ |
| WYY | WidePoint Corporation | Q3 2016 | 2016-11-09 | D |
| TGI | Triumph Group, Inc. | Q2 2017 | 2016-11-03 | C+ |
| NTCT | NetScout Systems, Inc. | Q2 2017 | 2016-10-27 | D |
| ARAY | Accuray Incorporated | Q4 2016 | 2016-08-17 | B |
| GES | Guess?, Inc. | Q1 2017 | 2016-05-25 | F |
| GOGO | Gogo Inc. | Q1 2016 | 2016-05-06 | C+ |
| SPR | Spirit AeroSystems Holdings, Inc. | Q1 2016 | 2016-04-29 | D |
| ACCO | ACCO Brands Corporation | Q1 2016 | 2016-04-27 | B+ |
| WK | Workiva Inc. | Q4 2015 | 2016-03-01 | B |
| HPP | Hudson Pacific Properties, Inc. | Q4 2015 | 2016-02-25 | C |
| ENLC | EnLink Midstream, LLC | Q4 2015 | 2016-02-17 | C+ |
| JJSF | J&J Snack Foods Corp. | Q1 2016 | 2016-01-26 | C |
DUOT · Q4 2023 → YESThe question is: Does management describe that MORE THAN ONE INDEPENDENT OUTSIDE PARTY has RECENTLY put something real of its own behind this company — money, orders, capacity, reputation, approval, o...NO The transcript mentions new AI subscription and support services contracts with two major railroads, which are concrete recent actions by two independent outside parties. However, management describes these as "just the beginning," indicating that the business implied is early relative to the company's reported size. This meets the criteria for YES under the specific conditions provided but the overall context of poor financials and the need for capital infusion suggests the actions may not fully align with the "validating a trajectory whose contribution is still mostly ahead" aspect in a way that overrides the NO criteria for rescue financing or balance-sheet repair. The patent grant is an approval but not a party putting money or orders behind the company in the required sense. Partnerships with Dell and NVIDIA are strengthened but not new concrete actions costing to reverse. Thus, the answer is NO.
TENB · Q2 2021 → YESThe question is about whether management describes more than one independent outside party recently putting something real behind the company, and treating this as validating a trajectory still mostly...YES The transcript shows management describing multiple independent outside parties taking concrete recent actions that validate the company's trajectory as still early relative to reported results. Specifically, NIST selected Tenable as one of 18 technologies for its Zero Trust initiative, granting formal approval and admission. Separately, the company entered a $375 million credit agreement with lenders to support growth, providing capital backing. These actions—approval and investment—are treated by management as endorsements of the business's early-stage potential, with references to ongoing deployments and pipeline activity in areas like OT and AD that exceed the current reported size. The parties are independent, and the actions are recent and in motion rather than reflective of fully realized results.
CRGO · Q1 2024 → YESThe question is: Does management describe that MORE THAN ONE INDEPENDENT OUTSIDE PARTY has RECENTLY put something real of its own behind this company — money, orders, capacity, reputation, approval, o...NO The transcript describes partnerships or expansions with United Airlines, Delta Cargo, Singapore Airlines, and Fits Cargo, but these are presented as ongoing or expanding relationships rather than new, concrete recent actions from multiple independent parties that validate an early-stage trajectory. The United Airlines example is a specific commitment to build a portal, yet the 49 carrier sellers and new additions are framed as rollouts already reflected in results, with pipeline mentions indicating future activity. Management connects these to growth but does not clearly treat the convergence as validating a trajectory mostly ahead of reported results in a way that meets the criteria for multiple independent endorsements with costly commitments.